(September 22, 2023, 11:16 AM EDT) -- ATLANTA — The 11th Circuit U.S. Court of Appeals on Sept. 21 affirmed a lower federal court’s ruling that an excess insurer has no duty to defend an opioid manufacturer insured against underlying lawsuits arising from the insured’s sale of prescription opioid medications, finding that the insured failed to provide timely notice of the underlying actions....